Loading...
XJPX9265
Market cap37mUSD
Jan 09, Last price  
2,383.00JPY
1D
-1.28%
1Q
-13.35%
IPO
41.93%
Name

Yamashita Health Care Holdings Inc

Chart & Performance

D1W1MN
XJPX:9265 chart
P/E
10.13
P/S
0.10
EPS
235.19
Div Yield, %
2.08%
Shrs. gr., 5y
-0.06%
Rev. gr., 5y
0.01%
Revenues
61.56b
+5.77%
47,132,000,00051,049,000,00050,310,000,00051,615,298,00052,517,963,00058,692,788,00061,533,254,00064,658,509,00070,131,078,00055,145,830,00058,195,000,00061,555,000,000
Net income
580m
+164.84%
321,000,000553,000,000359,000,000332,239,00019,408,000220,608,000144,422,000459,701,000678,492,000696,000,000219,000,000580,000,000
CFO
878m
-59.46%
176,000,0001,888,000,000-464,000,000276,907,000-1,710,090,0001,493,349,000-101,469,000817,815,000911,528,000581,267,0002,166,000,000878,000,000
Dividend
May 29, 20250 JPY/sh
Earnings
Mar 27, 2025

Profile

Yamashita Health Care Holdings,Inc. engages in the supply of medical equipment in Japan. The company offers diagnostic imaging devices, such as MRI and CT, endoscopic systems, operating tables, shadowless lights, and surgical equipment comprising electric scalpels, orthopedic implants, various catheters, and disposable medical materials; plans, manufactures, consigns, imports, and sells implants that are embedded in the body in the field of orthopedics; and sells and maintains medical equipment, which include dialysis machines/dialysis consumables, peritoneal dialysis, calculus crushing devices, and stents. It also provides consulting services related to the management of medical and long-term care institutions; and develops reservation solutions for hospitals consisting of search portal sites for hospitals and clinics, online reception, posting agency for customer satisfaction surveys, and network security systems sales. The company was founded in 1926 and is headquartered in Fukuoka City, Japan.
URL
https://www.yhchd.co.jp/
IPO date
Dec 01, 2017
Employees
570
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑052023‑052022‑052021‑052020‑052019‑052018‑052017‑052016‑052015‑05
Income
Revenues
61,555,000
5.77%
58,195,000
5.53%
55,145,830
-21.37%
Cost of revenue
60,533,000
51,410,000
48,652,653
Unusual Expense (Income)
NOPBT
1,022,000
6,785,000
6,493,177
NOPBT Margin
1.66%
11.66%
11.77%
Operating Taxes
293,000
423,000
330,023
Tax Rate
28.67%
6.23%
5.08%
NOPAT
729,000
6,362,000
6,163,154
Net income
580,000
164.84%
219,000
-68.53%
696,000
2.58%
Dividends
(122,000)
(209,000)
(229,998)
Dividend yield
1.79%
4.08%
4.65%
Proceeds from repurchase of equity
(165,000)
BB yield
2.43%
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
351,000
245,000
225,496
Net debt
(6,934,000)
(7,286,000)
(5,565,743)
Cash flow
Cash from operating activities
878,000
2,166,000
581,267
CAPEX
(74,000)
(81,000)
(118,560)
Cash from investing activities
(1,067,000)
(107,000)
(27,660)
Cash from financing activities
(335,000)
(209,000)
(229,998)
FCF
908,000
6,499,028
6,212,591
Balance
Cash
5,300,000
5,825,000
3,975,743
Long term investments
1,634,000
1,461,000
1,590,000
Excess cash
3,856,250
4,376,250
2,808,452
Stockholders' equity
7,271,000
7,296,000
7,377,670
Invested Capital
5,049,750
3,457,750
5,294,404
ROIC
17.14%
145.38%
111.25%
ROCE
11.39%
83.82%
77.27%
EV
Common stock shares outstanding
2,546
2,553
2,553
Price
2,671.00
33.22%
2,005.00
3.51%
1,937.00
-3.49%
Market cap
6,799,810
32.85%
5,118,536
3.51%
4,944,940
-3.49%
EV
(120,190)
(2,150,464)
(596,301)
EBITDA
1,235,000
6,988,000
6,714,797
EV/EBITDA
Interest
2,000
3,859
Interest/NOPBT
0.03%
0.06%